Senores Pharmaceuticals Limited

Key metrics

Price as of 2026-07-17

Stock price

₹1405.10

Market cap

6,470 Cr

Stock P/E

50.8

P/B

6.71

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly · ₹ Cr · tap + rows to expand

Metric	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025
Sales	103 Cr	114 Cr	138 Cr	162 Cr	175 Cr
Operating expenses (approx.)	72 Cr	83 Cr	100 Cr	107 Cr	117 Cr
EBITDA	31 Cr	31 Cr	38 Cr	55 Cr	58 Cr
OPM %	29.9%	27.3%	27.2%	34.0%	33.1%
Other income	5 Cr	12 Cr	3 Cr	5 Cr	4 Cr
Interest	6 Cr	5 Cr	5 Cr	6 Cr	5 Cr
Depreciation	4 Cr	5 Cr	6 Cr	8 Cr	8 Cr
Profit before tax	20 Cr	21 Cr	26 Cr	41 Cr	45 Cr
Tax %	19.8%	13.1%	20.0%	25.9%	24.7%
Net profit	16 Cr	18 Cr	21 Cr	30 Cr	34 Cr
EPS (₹)	₹5.04	₹3.81	₹4.60	₹6.54	₹7.29

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2025	Mar 2026	TTM
Sales	398 Cr	633 Cr	Sign in for TTM
Operating expenses (approx.)	289 Cr	417 Cr	Sign in for TTM
EBITDA	109 Cr	215 Cr	Sign in for TTM
OPM %	27.4%	34.0%	Sign in for TTM
Other income	19 Cr	47 Cr	Sign in for TTM
Interest	22 Cr	25 Cr	Sign in for TTM
Depreciation	17 Cr	31 Cr	Sign in for TTM
Profit before tax	71 Cr	159 Cr	Sign in for TTM
Tax %	17.3%	23.6%	Sign in for TTM
Net profit	58 Cr	122 Cr	Sign in for TTM
EPS (₹)	₹16.12	₹26.39	Sign in for TTM
Dividend payout %	0.0%	0.0%	Sign in for TTM

Trailing twelve months totals and margin rows

Annual · ₹ Cr · tap + rows to expand

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2025	Mar 2026
Cash from operating activity	-46 Cr	62 Cr
Cash from investing	-429 Cr	-121 Cr
Cash from financing	573 Cr	-1 Cr
Net cash flow	98 Cr	-60 Cr
Free cash flow (OCF − Capex)	-203 Cr	-178 Cr

Ratios as reported or derived per annual period.

Loading peers…